Madrigal Pharmaceuticals, Inc.

MDGL · Healthcare

$538.71

Capitalización: 12.45B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Madrigal Pharmaceuticals, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

GlobeNewswire2 sept 2026, 12:00

Madrigal Pharmaceuticals to Participate in the  2026 Cantor Global Healthcare Conference

Motley Fool25 ago 2026, 16:20

Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off

GlobeNewswire20 ago 2026, 20:05

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

MarketBeat15 ago 2026, 9:01

Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands